Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Anais Da Academia Brasileira De Ciencias
|
October 24, 2019
Response of duck breeders to dietary L-Carnitine supplementation during summer season
Yasser S Rizk, Hany N Fahim, Malak M Beshara, et al.
Carbohydrate Research
|
August 31, 1999
Inhibition of some hepatic lysosomal glycosidases by ethanolamines and phenyl 6-deoxy-6-(morpholin-4-yl)-beta-D-glucopyranoside
M Balbaa, N Abdel-Hady, F el-Rashidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials
E Mitry, J-Y Douillard, E Van Cutsem, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
April 19, 2023
Achieving optimal clinical outcomes in autologous fat grafting: A systematic review of processing techniques
B J Langridge, S Jasionowska, H Khan, et al.
Gait & Posture
|
July 10, 2018
O 089 - A soft robotic exosuit assisting the paretic ankle in patients post-stroke: Effect on muscle activation during overground walking
L Sloot, J Bae, L Baker, et al.
Revue Neurologique
|
January 1, 1984
[Methylation of erythrocyte membrane phospholipids: correlation with membrane viscosity. Study of normal and parkinsonian subjects]
V Meininger, T Phan, J C Camelin, et al.
The Oncologist
|
February 13, 2001
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard
L B Saltz, J Y Douillard, N Pirotta, et al.
British Journal of Cancer
|
August 17, 2000
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups
G Freyer, P Rougier, R Bugat, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
D Cunningham, S Pyrhönen, R D James, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Anais Da Academia Brasileira De Ciencias
|
October 24, 2019
Response of duck breeders to dietary L-Carnitine supplementation during summer season
Yasser S Rizk, Hany N Fahim, Malak M Beshara, et al.
Carbohydrate Research
|
August 31, 1999
Inhibition of some hepatic lysosomal glycosidases by ethanolamines and phenyl 6-deoxy-6-(morpholin-4-yl)-beta-D-glucopyranoside
M Balbaa, N Abdel-Hady, F el-Rashidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials
E Mitry, J-Y Douillard, E Van Cutsem, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
April 19, 2023
Achieving optimal clinical outcomes in autologous fat grafting: A systematic review of processing techniques
B J Langridge, S Jasionowska, H Khan, et al.
Gait & Posture
|
July 10, 2018
O 089 - A soft robotic exosuit assisting the paretic ankle in patients post-stroke: Effect on muscle activation during overground walking
L Sloot, J Bae, L Baker, et al.
Revue Neurologique
|
January 1, 1984
[Methylation of erythrocyte membrane phospholipids: correlation with membrane viscosity. Study of normal and parkinsonian subjects]
V Meininger, T Phan, J C Camelin, et al.
The Oncologist
|
February 13, 2001
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard
L B Saltz, J Y Douillard, N Pirotta, et al.
British Journal of Cancer
|
August 17, 2000
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups
G Freyer, P Rougier, R Bugat, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
D Cunningham, S Pyrhönen, R D James, et al.
Page
of 3